[ad_1]
Ashraf Hatem, a former Minister of Health and a member of the Higher Committee on Hepatitis Viruses, said the succession of announcements of potential vaccines, starting with Pfizer and ending with the American company Moderna today, has nothing to do. with the US elections, but it represents quite a natural development of the clinical trials these companies have been working on for some time, especially AND that there are about 7 types of potential vaccines, which will begin to be announced at the end of 2020.
Hatem continued in a telephone interview with the “last word” program presented by Mays Al-Hadidi on the “ON” channel that within a week or two at the latest, Astra Zenica will announce the Oxford vaccine, as well as another American vaccine and 2 in China in addition to the two Russian vaccines.
He added that all of this is a natural result of the clinical trials that have taken place over the past six months, revealing that the difference between the two vaccines, Pfizer and our potential MDR, is not great, but rather they are very similar in that they are a fax type called “RNA” fax, which is a type of fax that is being used for the first time. And it works on the same DNA, but the difference here is that the Moderna vaccine stimulates the body’s immunity to resist faxes and is used twice, the first followed by the second within 28 days, but the Pfizer vaccine problem is the methods of storage, as it requires very cold temperatures reaching minus The temperature of 70 degrees will face a big problem in the transportation process.
Continue: For the Moderna vaccine, it depends on a taste that is stored at a temperature of 2-8 degrees Celsius and can be stored in the regular refrigerator. Therefore, the Moderna vaccine has preference in the transport process, and therefore there is an expectation that it will be much better than the Pfizer vaccine.
.
[ad_2]
Source link
